{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T09:38:09Z","timestamp":1781429889464,"version":"3.54.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15337-9","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T10:03:02Z","timestamp":1768212182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IGF2BP3\/m6A-mediated intron retention isoform of DUSP6 promotes cisplatin resistance in nasopharyngeal carcinoma by inhibiting pyroptosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaochen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"15337_CR1","doi-asserted-by":"publisher","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet. 2024;286\u20137. https:\/\/doi.org\/10.1016\/j.cancergen.2024.06.002.","DOI":"10.1016\/j.cancergen.2024.06.002"},{"issue":"10192","key":"15337_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s0140-6736(19)30956-0","volume":"394","author":"Y-P Chen","year":"2019","unstructured":"Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64\u201380. https:\/\/doi.org\/10.1016\/s0140-6736(19)30956-0.","journal-title":"Lancet"},{"issue":"6","key":"15337_CR3","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1158\/1055-9965.Epi-20-1702","volume":"30","author":"ET Chang","year":"2021","unstructured":"Chang ET, Ye W, Zeng Y-X, Adami H-O. The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2021;30(6):1035\u201347. https:\/\/doi.org\/10.1158\/1055-9965.Epi-20-1702.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"15337_CR4","doi-asserted-by":"publisher","unstructured":"Guan S, Wei J, Huang L, Wu L. Chemotherapy and chemo-resistance in nasopharyngeal carcinoma. Eur J Med Chem. 2020;207. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112758.","DOI":"10.1016\/j.ejmech.2020.112758"},{"issue":"6","key":"15337_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/s1470-2045(15)70126-9","volume":"16","author":"P Blanchard","year":"2015","unstructured":"Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, et al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol. 2015;16(6):645\u201355. https:\/\/doi.org\/10.1016\/s1470-2045(15)70126-9.","journal-title":"Lancet Oncol"},{"issue":"2","key":"15337_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5306\/wjco.v4.i2.47","volume":"4","author":"F Perri","year":"2013","unstructured":"Perri F, Della Vittoria Scarpati G, Buonerba C, Di Lorenzo G, Longo F, Muto P, et al. Combined chemo-radiotherapy in locally advanced nasopharyngeal carcinomas. World J Clin Oncol. 2013;4(2):47\u201351. https:\/\/doi.org\/10.5306\/wjco.v4.i2.47.","journal-title":"World J Clin Oncol"},{"issue":"7","key":"15337_CR7","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/(sici)1097-0142(19970401)79:7<1279::aid-cncr2>3.0.co;2-c","volume":"79","author":"FB Geara","year":"1997","unstructured":"Geara FB, Glisson BS, Sanguineti G, Tucker SL, Garden AS, Ang KK, et al. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study. Cancer. 1997;79(7):1279\u201386. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19970401)79:7%3C1279::aid-cncr2%3E3.0.co;2-c.","journal-title":"Cancer"},{"issue":"12","key":"15337_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.5306\/wjco.v2.i12.377","volume":"2","author":"F Perri","year":"2011","unstructured":"Perri F, Bosso D, Buonerba C, Lorenzo GD, Scarpati GD. Locally advanced nasopharyngeal carcinoma: current and emerging treatment strategies. World J Clin Oncol. 2011;2(12):377\u201383. https:\/\/doi.org\/10.5306\/wjco.v2.i12.377.","journal-title":"World J Clin Oncol"},{"key":"15337_CR9","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2147\/ott.S188148","volume":"12","author":"F Perri","year":"2019","unstructured":"Perri F, Della Vittoria Scarpati G, Caponigro F, Ionna F, Longo F, Buonopane S, et al. Management of recurrent nasopharyngeal carcinoma: current perspectives. OncoTargets Therapy. 2019;121583\u201391. https:\/\/doi.org\/10.2147\/ott.S188148.","journal-title":"OncoTargets Therapy"},{"issue":"7","key":"15337_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrm.2017.27","volume":"18","author":"FE Baralle","year":"2017","unstructured":"Baralle FE, Giudice J. Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol. 2017;18:(7):437\u201351. https:\/\/doi.org\/10.1038\/nrm.2017.27.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"15337_CR11","doi-asserted-by":"publisher","first-page":"100728","DOI":"10.1016\/j.drup.2020.100728","volume":"53","author":"R Sciarrillo","year":"2020","unstructured":"Sciarrillo R, Wojtuszkiewicz A, Assaraf YG, Jansen G, Kaspers GJL, Giovannetti E, et al. The role of alternative splicing in cancer: from oncogenesis to drug resistance. Drug Resist Updat. 2020;53:100728. https:\/\/doi.org\/10.1016\/j.drup.2020.100728.","journal-title":"Drug Resist Updat"},{"issue":"6","key":"15337_CR12","doi-asserted-by":"publisher","first-page":"101077","DOI":"10.1016\/j.tranon.2021.101077","volume":"14","author":"K Deng","year":"2021","unstructured":"Deng K, Yao J, Huang J, Ding Y, Zuo J. Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy. Transl Oncol. 2021;14(6):101077. https:\/\/doi.org\/10.1016\/j.tranon.2021.101077.","journal-title":"Transl Oncol"},{"key":"15337_CR13","doi-asserted-by":"publisher","unstructured":"Zhang J, Jiang H, Xie T, Zheng J, Tian Y, Li R, et al. Differential expression and alternative splicing of transcripts associated with Cisplatin-Induced chemoresistance in nasopharyngeal carcinoma. Front Genet. 2020;11. https:\/\/doi.org\/10.3389\/fgene.2020.00052.","DOI":"10.3389\/fgene.2020.00052"},{"issue":"7377","key":"15337_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature10662","volume":"480","author":"PI Poulikakos","year":"2011","unstructured":"Poulikakos PI, Persaud Y, Janakiraman M, Kong X, Ng C, Moriceau G, et al. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature. 2011;480(7377):387\u201390. https:\/\/doi.org\/10.1038\/nature10662.","journal-title":"Nature"},{"issue":"12","key":"15337_CR15","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1080\/15476286.2018.1551692","volume":"15","author":"A Tyson-Capper","year":"2018","unstructured":"Tyson-Capper A, Gautrey H. Regulation of Mcl-1 alternative splicing by HnRNP F, H1 and K in breast cancer cells. RNA Biol. 2018;15(12):1448\u201357. https:\/\/doi.org\/10.1080\/15476286.2018.1551692.","journal-title":"RNA Biol"},{"issue":"4","key":"15337_CR16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1074\/mcp.M115.052944","volume":"15","author":"A Wojtuszkiewicz","year":"2016","unstructured":"Wojtuszkiewicz A, Schuurhuis GJ, Kessler FL, Piersma SR, Knol JC, Pham TV, et al. Exosomes secreted by apoptosis-Resistant acute myeloid leukemia (AML) blasts harbor regulatory network proteins potentially involved in antagonism of apoptosis. Mol Cell Proteomics: MCP. 2016;15(4):1281\u201398. https:\/\/doi.org\/10.1074\/mcp.M115.052944.","journal-title":"Mol Cell Proteomics: MCP"},{"key":"15337_CR17","doi-asserted-by":"publisher","unstructured":"Haugh AM, Johnson DB, V600K BRAF-Mutant Melanoma. Management of V600E and. Curr Treat Options Oncol. 2019; 20(11):81. https:\/\/doi.org\/10.1007\/s11864-019-0680-z","DOI":"10.1007\/s11864-019-0680-z"},{"key":"15337_CR18","doi-asserted-by":"publisher","unstructured":"Vasudevan SO, Behl B, Rathinam VA. Pyroptosis-induced inflammation and tissue damage. Semin Immunol. 2023;69. https:\/\/doi.org\/10.1016\/j.smim.2023.101781.","DOI":"10.1016\/j.smim.2023.101781"},{"issue":"7575","key":"15337_CR19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660\u20135. https:\/\/doi.org\/10.1038\/nature15514.","journal-title":"Nature"},{"issue":"4","key":"15337_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","volume":"42","author":"J Shi","year":"2017","unstructured":"Shi J, Gao W, Shao F. Pyroptosis: Gasdermin-Mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42(4):245\u201354. https:\/\/doi.org\/10.1016\/j.tibs.2016.10.004.","journal-title":"Trends Biochem Sci"},{"key":"15337_CR21","doi-asserted-by":"publisher","first-page":"1173235","DOI":"10.3389\/fcell.2023.1173235","volume":"11","author":"R Chai","year":"2023","unstructured":"Chai R, Li Y, Shui L, Ni L, Zhang A. The role of pyroptosis in inflammatory diseases. Front Cell Dev Biology. 2023;11:1173235. https:\/\/doi.org\/10.3389\/fcell.2023.1173235.","journal-title":"Front Cell Dev Biology"},{"issue":"5","key":"15337_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10565-020-09514-8","volume":"36","author":"X Wang","year":"2020","unstructured":"Wang X, Li H, Li W, Xie J, Wang F, Peng X, et al. The role of Caspase-1\/GSDMD-mediated pyroptosis in Taxol-induced cell death and a Taxol-resistant phenotype in nasopharyngeal carcinoma regulated by autophagy. Cell Biol Toxicol. 2020;36(5):437\u201357. https:\/\/doi.org\/10.1007\/s10565-020-09514-8.","journal-title":"Cell Biol Toxicol"},{"key":"15337_CR23","doi-asserted-by":"publisher","unstructured":"Chen Z, Xu G, Wu D, Wu S, Gong L, Li Z, et al. Lobaplatin induces pyroptosis through regulating cIAP1\/2, Ripoptosome and ROS in nasopharyngeal carcinoma. Biochem Pharmacol. 2020;177. https:\/\/doi.org\/10.1016\/j.bcp.2020.114023.","DOI":"10.1016\/j.bcp.2020.114023"},{"key":"15337_CR24","doi-asserted-by":"publisher","unstructured":"Kong Q, Xia S, Pan X, Ye K, Li Z, Li H, et al. Alternative splicing of GSDMB modulates killer lymphocyte\u2013triggered pyroptosis. Sci Immunol. 2023;8(82). https:\/\/doi.org\/10.1126\/sciimmunol.adg3196.","DOI":"10.1126\/sciimmunol.adg3196"},{"key":"15337_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-023-01284-y","author":"K Bi","year":"2023","unstructured":"Bi K, Yang J, Wei X. Alternative splicing variants involved in pyroptosis and Cuproptosis contribute to phenotypic remodeling of the tumor microenvironment in cervical cancer. Reproductive Sci. 2023. https:\/\/doi.org\/10.1007\/s43032-023-01284-y.","journal-title":"Reproductive Sci"},{"issue":"1","key":"15337_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s43018-022-00486-8","volume":"4","author":"T Kong","year":"2023","unstructured":"Kong T, Laranjeira ABA, Yang K, Fisher DAC, Yu L, Poittevin De La Fr\u00e9gonni\u00e8re L, et al. DUSP6 mediates resistance to JAK2 Inhibition and drives leukemic progression. Nat Cancer. 2023;4(1):108\u201327. https:\/\/doi.org\/10.1038\/s43018-022-00486-8.","journal-title":"Nat Cancer"},{"issue":"12","key":"15337_CR27","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/s41588-021-00967-z","volume":"53","author":"T Ito","year":"2021","unstructured":"Ito T, Young MJ, Li R, Jain S, Wernitznig A, Krill-Burger JM, et al. Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers. Nat Genet. 2021;53(12):1664\u201372. https:\/\/doi.org\/10.1038\/s41588-021-00967-z.","journal-title":"Nat Genet"},{"issue":"4","key":"15337_CR28","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1080\/10495398.2021.2016433","volume":"34","author":"Q Wang","year":"2023","unstructured":"Wang Q, Zhang L, Qu J, Wu X, Sun X, Ji D, et al. DUSP6 inhibits the proliferation of hair follicle stem cells (HFSCs) in vitro. Anim Biotechnol. 2023;34(4):1223\u201331. https:\/\/doi.org\/10.1080\/10495398.2021.2016433.","journal-title":"Anim Biotechnol"},{"issue":"1","key":"15337_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ijc.25970","volume":"130","author":"VC Wong","year":"2012","unstructured":"Wong VC, Chen H, Ko JM, Chan KW, Chan YP, Law S, et al. Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype. Int J Cancer. 2012;130(1):83\u201395. https:\/\/doi.org\/10.1002\/ijc.25970.","journal-title":"Int J Cancer"},{"key":"15337_CR30","doi-asserted-by":"publisher","unstructured":"Ou L, Zhu Z, Hao Y, Li Q, Liu H, Chen Q, et al. 1,3,6-Trigalloylglucose: A novel potent Anti-Helicobacter pylori adhesion agent derived from aqueous extracts of terminalia chebula Retz. Molecules. 2024;29(5). https:\/\/doi.org\/10.3390\/molecules29051161.","DOI":"10.3390\/molecules29051161"},{"key":"15337_CR31","doi-asserted-by":"publisher","first-page":"1416794","DOI":"10.3389\/fmicb.2024.1416794","volume":"15","author":"L Ou","year":"2024","unstructured":"Ou L, Hao Y, Liu H, Zhu Z, Li Q, Chen Q, et al. Chebulinic acid isolated from aqueous extracts of terminalia chebula Retz inhibits Helicobacter pylori infection by potential binding to Cag A protein and regulating adhesion. Front Microbiol. 2024;15:1416794. https:\/\/doi.org\/10.3389\/fmicb.2024.1416794.","journal-title":"Front Microbiol"},{"issue":"12","key":"15337_CR32","first-page":"2346","volume":"8","author":"LY Zhu","year":"2018","unstructured":"Zhu LY, Zhu YR, Dai DJ, Wang X, Jin HC. Epigenetic regulation of alternative splicing. Am J Cancer Res. 2018;8(12):2346\u201358.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"15337_CR33","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1111\/jcmm.13491","volume":"22","author":"Z Feng","year":"2018","unstructured":"Feng Z, Li Q, Meng R, Yi B, Xu Q. METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells. J Cell Mol Med. 2018;22(5):2558\u201368. https:\/\/doi.org\/10.1111\/jcmm.13491.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"15337_CR34","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","volume":"169","author":"KE Pendleton","year":"2017","unstructured":"Pendleton KE, Chen B, Liu K, Hunter OV, Xie Y, Tu BP, et al. The U6 SnRNA m(6)A methyltransferase METTL16 regulates SAM synthetase intron retention. Cell. 2017;169(5):824\u2013e835814. https:\/\/doi.org\/10.1016\/j.cell.2017.05.003.","journal-title":"Cell"},{"issue":"3","key":"15337_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20(3):285\u201395. https:\/\/doi.org\/10.1038\/s41556-018-0045-z.","journal-title":"Nat Cell Biol"},{"issue":"10","key":"15337_CR36","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1093\/nar\/gkv210","volume":"43","author":"M Danan-Gotthold","year":"2015","unstructured":"Danan-Gotthold M, Golan-Gerstl R, Eisenberg E, Meir K, Karni R, Levanon EY. Identification of recurrent regulated alternative splicing events across human solid tumors. Nucleic Acids Res. 2015;43(10):5130\u201344. https:\/\/doi.org\/10.1093\/nar\/gkv210.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"15337_CR37","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s41419-025-08084-z","volume":"16","author":"I Krossa","year":"2025","unstructured":"Krossa I, Pisibon C, Cheli Y, Bille K, Dalmasso M, Hamadat S, et al. SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic target. Cell Death Dis. 2025;16(1):754. https:\/\/doi.org\/10.1038\/s41419-025-08084-z.","journal-title":"Cell Death Dis"},{"issue":"1","key":"15337_CR38","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1186\/s12967-025-07156-0","volume":"23","author":"C Li","year":"2025","unstructured":"Li C, Peng W, Zhong Z, Zhang C, Wang X, Qin R, et al. CRISPR\/Cas9 library screening reveals that STK19 has synergistic antitumor effects when combined with cisplatin on tongue squamous cell carcinoma. J Translational Med. 2025;23(1):1142. https:\/\/doi.org\/10.1186\/s12967-025-07156-0.","journal-title":"J Translational Med"},{"key":"15337_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.leukres.2016.08.006","volume":"49","author":"E Berman","year":"2016","unstructured":"Berman E, Jhanwar S, Hedvat C, Arcila ME, Wahab OA, Levine R, et al. Resistance to Imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS). Leuk Res. 2016;49:108\u201312. https:\/\/doi.org\/10.1016\/j.leukres.2016.08.006.","journal-title":"Leuk Res"},{"key":"15337_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/ott.S53876","volume":"7","author":"S Surget","year":"2013","unstructured":"Surget S, Khoury MP, Bourdon JC. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. OncoTargets Therapy. 2013;7:57\u201368. https:\/\/doi.org\/10.2147\/ott.S53876.","journal-title":"OncoTargets Therapy"},{"issue":"6","key":"15337_CR41","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1158\/1078-0432.Ccr-07-1422","volume":"14","author":"KA Avery-Kiejda","year":"2008","unstructured":"Avery-Kiejda KA, Zhang XD, Adams LJ, Scott RJ, Vojtesek B, Lane DP, et al. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin. Clin Cancer Research: Official J Am Association Cancer Res. 2008;14(6):1659\u201368. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-07-1422.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"key":"15337_CR42","doi-asserted-by":"publisher","unstructured":"Chen Z, Er Saw P, Integration in Biomedical Science. 2024: Emerging Trends in the Post-Pandemic Era. BIO Integration. 2024; 5(1):1\u20132. https:\/\/doi.org\/10.15212\/bioi-2024-1001","DOI":"10.15212\/bioi-2024-1001"},{"issue":"13","key":"15337_CR43","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.Can-22-3059","volume":"83","author":"Z Lin","year":"2023","unstructured":"Lin Z, Li J, Zhang J, Feng W, Lu J, Ma X, et al. Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in Non-Small cell lung cancer. Cancer Res. 2023;83(13):2187\u2013207. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-3059.","journal-title":"Cancer Res"},{"issue":"9","key":"15337_CR44","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41419-023-06099-y","volume":"14","author":"LJ Chen","year":"2023","unstructured":"Chen LJ, Liu HY, Xiao ZY, Qiu T, Zhang D, Zhang LJ, et al. IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m(6)A-dependent manner. Cell Death Dis. 2023;14(9):581. https:\/\/doi.org\/10.1038\/s41419-023-06099-y.","journal-title":"Cell Death Dis"},{"key":"15337_CR45","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3389\/fbioe.2020.00679","volume":"8","author":"H Xueqing","year":"2020","unstructured":"Xueqing H, Jun Z, Yueqiang J, Xin L, Liya H, Yuanyuan F, et al. IGF2BP3 May contributes to lung tumorigenesis by regulating the alternative splicing of PKM. Front Bioeng Biotechnol. 2020;8:679. https:\/\/doi.org\/10.3389\/fbioe.2020.00679.","journal-title":"Front Bioeng Biotechnol"},{"issue":"7661","key":"15337_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, Ding J, Liu W, He H, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547(7661):99\u2013103. https:\/\/doi.org\/10.1038\/nature22393.","journal-title":"Nature"},{"issue":"8","key":"15337_CR47","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.apsb.2020.06.015","volume":"10","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhang P, An L, Sun N, Peng L, Tang W, et al. Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis. Acta Pharm Sin B. 2020;10(8):1397\u2013413. https:\/\/doi.org\/10.1016\/j.apsb.2020.06.015.","journal-title":"Acta Pharm Sin B"},{"issue":"82","key":"15337_CR48","doi-asserted-by":"publisher","first-page":"eadg3196","DOI":"10.1126\/sciimmunol.adg3196","volume":"8","author":"Q Kong","year":"2023","unstructured":"Kong Q, Xia S, Pan X, Ye K, Li Z, Li H, et al. Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis. Sci Immunol. 2023;8(82):eadg3196. https:\/\/doi.org\/10.1126\/sciimmunol.adg3196.","journal-title":"Sci Immunol"},{"issue":"7957","key":"15337_CR49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-05872-5","volume":"616","author":"X Zhong","year":"2023","unstructured":"Zhong X, Zeng H, Zhou Z, Su Y, Cheng H, Hou Y, et al. Structural mechanisms for regulation of GSDMB pore-forming activity. Nature. 2023;616(7957):598\u2013605. https:\/\/doi.org\/10.1038\/s41586-023-05872-5.","journal-title":"Nature"},{"key":"15337_CR50","doi-asserted-by":"publisher","unstructured":"Yan L, Sun Y, Guo J, Jia R. PD-L1 exon 3 is a hidden switch of its expression and function in oral cancer cells. Int J Mol Sci. 2023;24(9). https:\/\/doi.org\/10.3390\/ijms24098193.","DOI":"10.3390\/ijms24098193"},{"key":"15337_CR51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cancergen.2025.04.006","volume":"294\u2013295","author":"D Gu","year":"2025","unstructured":"Gu D, Sun Y, Wang J, Sun J, Lou H, Kang W. Metformin regulates ferroptosis in skin cutaneous melanoma via ATF3\/NRF2 axis. Cancer Genet. 2025;294\u2013295:136\u201344. https:\/\/doi.org\/10.1016\/j.cancergen.2025.04.006.","journal-title":"Cancer Genet"},{"key":"15337_CR52","doi-asserted-by":"publisher","first-page":"952290","DOI":"10.3389\/fonc.2022.952290","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of Cuproptosis and copper metabolism-related gene set. Front Oncol. 2022;12:952290. https:\/\/doi.org\/10.3389\/fonc.2022.952290.","journal-title":"Front Oncol"},{"key":"15337_CR53","doi-asserted-by":"publisher","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 2023;278\u20139. https:\/\/doi.org\/10.1016\/j.cancergen.2023.10.001.","DOI":"10.1016\/j.cancergen.2023.10.001"},{"key":"15337_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.70214","author":"QQ Yu","year":"2025","unstructured":"Yu QQ, Quan C, Li Y, Sun R. Paradoxical role and therapeutic potential of autophagy in lymphomas. Br J Haematol. 2025. https:\/\/doi.org\/10.1111\/bjh.70214.","journal-title":"Br J Haematol"},{"key":"15337_CR55","doi-asserted-by":"publisher","first-page":"102394","DOI":"10.1016\/j.mtbio.2025.102394","volume":"35","author":"Z Qi","year":"2025","unstructured":"Qi Z, Yan Y, Xu Z, Chong W, Qiu Y, Huang X, et al. Molybdenum disulfide induces growth Inhibition and autophagy-dependent hepatocyte cell death through directly binding and regulating the activity of MST2. Mater Today Bio. 2025;35:102394. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102394.","journal-title":"Mater Today Bio"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15337-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15337-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15337-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:03:00Z","timestamp":1770768180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15337-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15337"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15337-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the animal experiments in this study were authorized by the Laboratory Animal Ethics Committee of the Sixth Affiliated Hospital of Sun Yat-sen University (Approval No.IACUC-2024020201). Clinical tissue samples were used with permission from the Ethics Committee of the Sixth Affiliated Hospital of Sun Yat-sen University (Approval Number: 2021ZSLYEC-270).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}